| Cytarabine |
ENSG00000100181.17 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000132832.5 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000145063.10 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000152931.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000152931.7 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000157306.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000160336.10 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000164621.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000170161.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000171889.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000172250.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000174365.15 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000174365.15 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000175611.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000175873.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000177337.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000177640.11 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000178947.8 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000178947.8 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000179219.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000179219.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000179406.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000179743.2 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000180139.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000180279.5 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000181097.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000182109.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000182376.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000182586.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000182648.7 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000182648.7 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000182873.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000182873.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000183242.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000183242.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000183674.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000184274.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000185044.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000185168.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000185203.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000186148.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000187904.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000187979.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000188206.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000188365.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000189196.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000189229.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000189419.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000196559.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000196756.7 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000196756.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000197085.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000197558.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000198106.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000198468.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000203279.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000203280.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000203280.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000203288.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000203288.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000203307.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000203327.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000203327.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000203362.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000203496.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000203497.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000203497.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000203499.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000203585.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000203601.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000203706.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000203801.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000203808.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000203999.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000204054.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000204758.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000204832.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000204934.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000205037.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000205054.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000205559.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000205634.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000205885.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000206028.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000206337.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000206417.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000212694.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000212694.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000212978.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000213468.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000213963.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000213971.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000214432.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000214650.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000214650.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000214650.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000214733.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000214770.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000214770.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000214955.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000214955.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000215023.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000215068.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000215374.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000215458.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000215859.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000215863.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000215869.3 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000216863.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000218510.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000220161.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000222035.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000222044.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000223374.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000223387.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000223393.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000223401.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000223458.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000223473.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000223478.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000223522.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000223528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000223571.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000223576.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000223635.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000223635.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000223678.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000223711.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000223714.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000223714.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000223799.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000223855.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000223891.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000223935.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000223979.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000224046.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000224049.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000224050.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000224063.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000224086.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000224138.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000224141.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000224165.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000224174.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000224220.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000224269.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000224271.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000224292.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000224356.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000224424.7 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000224429.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000224481.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000224490.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000224541.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000224596.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000224614.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000224614.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000224616.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000224616.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000224635.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000224644.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000224660.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000224699.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000224699.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000224789.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000224790.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000224794.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000224799.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000224804.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000224818.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000224842.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000224863.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000224871.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000224884.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000224885.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000224888.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000224945.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000224969.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000224995.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000225039.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000225057.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000225138.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000225180.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000225205.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000225216.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000225234.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000225235.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000225235.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000225235.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000225265.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000225265.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000225265.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000225278.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000225335.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000225335.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000225353.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000225434.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000225446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000225490.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000225498.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000225506.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000225506.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000225506.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000225518.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000225555.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000225684.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000225745.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000225761.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000225783.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000225798.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000225872.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000225891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000225914.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000225975.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000225978.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000226007.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000226101.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000226155.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000226179.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000226272.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000226291.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000226310.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000226310.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000226312.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000226375.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000226381.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000226381.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000226383.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000226383.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000226386.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000226419.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000226440.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000226445.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000226453.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000226454.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000226496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000226578.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000226581.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000226637.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000226645.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000226648.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000226686.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000226690.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000226711.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000226746.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000226754.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000226754.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000226754.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000226756.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000226786.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000226819.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000226819.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000226851.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000226852.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000226853.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000226853.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000226856.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000226891.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000226913.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000226920.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000226957.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000227028.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000227028.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000227039.2 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000227116.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000227116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000227117.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000227172.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000227200.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000227285.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000227398.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000227431.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000227438.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000227484.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000227492.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000227492.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000227502.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000227527.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000227527.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000227542.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000227543.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000227603.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000227603.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000227630.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000227640.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000227695.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000227704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000227719.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000227740.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000227848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000227925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000227946.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000228013.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000228016.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000228065.6 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000228067.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000228072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000228084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000228109.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000228126.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000228140.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000228141.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000228192.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000228201.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000228222.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000228265.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000228274.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000228288.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000228350.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000228369.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000228369.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000228372.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000228386.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000228386.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000228386.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000228395.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000228397.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000228412.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000228463.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000228487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000228495.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000228506.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000228506.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000228566.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000228577.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000228598.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000228634.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000228649.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000228649.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000228686.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000228701.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000228705.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000228775.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000228775.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000228779.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000228786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000228786.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000228801.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000228801.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000228802.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000228824.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000228852.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000228852.2 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000228886.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000228889.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000228917.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000228956.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000228962.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000228972.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000228973.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000228989.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000229065.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000229065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000229105.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000229124.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000229137.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000229137.2 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000229162.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000229191.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000229243.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000229278.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000229401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000229463.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000229487.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000229498.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000229521.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000229531.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000229536.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000229582.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000229589.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000229591.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000229666.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000229719.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000229766.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000229776.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000229780.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000229839.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000229841.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000229848.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000229867.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000229891.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000229905.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000229931.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000229951.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000229970.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000229983.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000229999.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000229999.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000230001.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000230002.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000230005.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000230010.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000230054.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000230061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000230065.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000230176.2 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000230184.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000230366.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000230366.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000230401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000230410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000230415.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000230432.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000230433.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000230433.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000230479.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000230487.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000230513.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000230513.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000230523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000230530.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000230536.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000230542.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000230552.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000230561.3 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000230606.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000230613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000230615.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000230679.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000230736.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000230825.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000230850.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000230881.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000230896.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000230925.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000230939.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000231010.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000231050.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000231050.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000231073.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000231083.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000231113.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000231154.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000231196.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000231212.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000231217.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000231217.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000231249.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000231249.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000231290.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000231290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000231298.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000231305.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000231310.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000231327.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000231346.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000231367.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000231367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000231422.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000231439.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000231439.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000231521.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000231527.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000231528.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000231536.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000231595.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000231616.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000231636.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000231652.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000231703.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000231709.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000231711.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000231728.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000231734.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000231742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000231742.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000231770.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000231795.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000231806.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000231806.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000231851.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000231856.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000231856.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000231944.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000231966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000231969.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000231999.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000232021.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000232021.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000232028.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000232057.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000232104.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000232124.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000232184.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000232194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000232233.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000232274.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000232290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000232295.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000232328.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000232347.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000232386.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000232406.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000232412.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000232442.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000232445.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000232445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000232455.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000232461.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000232485.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000232504.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000232504.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000232519.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000232536.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000232600.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000232611.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000232613.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000232640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000232645.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000232710.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000232756.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000232788.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000232814.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000232827.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000232860.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000232874.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000232876.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000232907.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000232912.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000232956.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000233008.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000233016.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000233016.2 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000233033.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000233056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000233061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000233064.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000233069.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000233073.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000233077.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000233080.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000233143.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000233144.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000233220.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000233223.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000233237.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000233246.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000233246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000233250.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000233367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000233411.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000233427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000233429.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000233478.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000233515.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000233540.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000233593.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000233593.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000233611.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000233627.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000233654.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000233665.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000233695.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000233791.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000233806.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000233818.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000233847.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000233860.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000233862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000233937.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000233937.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000234006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000234006.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000234035.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000234062.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000234084.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000234084.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000234171.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000234183.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000234183.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000234185.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000234193.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000234230.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000234230.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000234232.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000234235.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000234235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000234255.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000234281.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000234327.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000234352.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000234361.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000234396.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000234445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000234456.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000234456.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000234503.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000234509.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000234571.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000234614.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000234614.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000234617.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000234630.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000234650.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000234676.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000234678.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000234698.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000234705.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000234722.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000234741.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000234753.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000234753.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000234789.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000234832.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000234869.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000234869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000234869.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000234880.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000234884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000234899.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000234902.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000234913.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000234917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000234917.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000234936.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000235079.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000235092.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000235100.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000235106.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000235117.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000235123.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000235138.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000235159.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000235159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000235172.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000235214.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000235245.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000235245.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000235246.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000235257.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000235262.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000235280.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000235298.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000235313.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000235326.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000235358.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000235366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000235381.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000235426.2 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000235437.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000235477.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000235494.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000235501.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000235545.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000235560.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000235593.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000235609.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000235659.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000235663.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000235790.3 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000235795.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000235802.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000235802.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000235806.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000235887.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000235888.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000235903.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000235910.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000235954.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000236031.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000236066.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000236066.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000236098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000236115.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000236153.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000236199.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000236200.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000236230.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000236234.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000236256.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000236256.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000236305.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000236366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000236388.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000236423.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000236472.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000236472.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000236514.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000236514.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000236514.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000236537.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000236537.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000236558.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000236617.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000236682.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000236682.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000236703.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000236859.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000236859.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000236859.2 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000237015.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000237017.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000237037.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000237126.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000237133.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000237152.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000237181.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000237310.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000237331.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000237341.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000237359.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000237404.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000237424.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000237461.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000237485.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000237517.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000237520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000237520.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000237523.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000237523.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000237548.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000237576.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000237588.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000237595.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000237609.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000237689.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000237738.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000237738.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000237750.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000237756.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000237756.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000237772.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000237805.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000237813.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000237853.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000237870.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000237883.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000237886.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000237892.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000237903.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000237928.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000237950.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000237993.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000237998.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000238005.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000238039.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000238039.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000238039.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000238042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000238107.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000238113.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000238133.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000238140.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000238141.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000238142.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000238184.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000238186.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000238186.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000238197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000238197.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000238198.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000238261.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000238268.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000239002.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000239002.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000239213.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000239353.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000239353.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000239462.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000239480.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000239523.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000239664.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000239801.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000239828.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000239911.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000239911.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000240006.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000240006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000240063.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000240063.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000240137.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000240175.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000240211.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000240291.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000240291.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000240405.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000240440.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000240449.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000240541.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000240661.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000240758.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000240859.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000240915.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000241014.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000241042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000241481.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000241490.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000241520.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000241520.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000241570.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000241818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000241832.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000241954.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000241954.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000241985.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000241990.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000242094.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000242125.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000242147.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000242154.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000242282.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000242553.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000242759.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000242770.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000242808.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000243008.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000243055.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000243144.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000243368.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000243415.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000243485.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000243485.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000243629.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000243810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000243819.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000243885.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000243960.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000244124.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000244137.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000244161.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000244184.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000244198.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000244252.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000244252.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000244327.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000244332.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000244383.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000244513.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000244558.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000244625.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000244879.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000244879.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000244952.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000245059.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000245059.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000245060.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000245213.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000245248.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000245498.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000245526.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000245534.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000245552.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000245571.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000245614.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000245648.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000245685.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000245729.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000245748.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000245928.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000245937.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000245975.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000246067.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000246130.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000246130.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000246174.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000246174.3 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000246225.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000246250.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000246339.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000246465.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000246465.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000246526.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000246526.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000246640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000246731.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000246763.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000246792.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000246792.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000246792.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000246859.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000246982.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000247134.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000247199.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000247311.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000247311.2 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000247317.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000247400.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000247595.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000247595.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000247675.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000247708.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000247796.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000247796.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000247853.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000247925.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000247950.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000247970.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000247982.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000248100.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000248103.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000248161.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000248175.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000248187.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000248238.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000248240.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000248245.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000248254.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000248323.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000248367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000248367.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000248468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000248514.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000248515.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000248538.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000248559.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000248599.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000248647.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000248664.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000248664.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000248771.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000248846.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000248932.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000248936.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000248968.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000249102.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000249234.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000249356.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000249359.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000249593.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000249595.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000249602.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000249602.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000249609.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000249609.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000249650.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000249684.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000249717.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000249717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000249740.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000249791.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000249835.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000249859.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000249859.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000249859.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000249867.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000249867.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000249896.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000250012.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000250027.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000250033.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000250072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000250075.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000250101.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000250132.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000250222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000250271.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000250286.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000250286.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000250312.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000250343.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000250362.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000250508.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000250596.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000250608.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000250616.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000250616.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000250734.2 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000250802.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000250820.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000250829.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000250842.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000250899.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000250948.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000250961.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000250986.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000251023.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000251031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000251059.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000251072.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000251072.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000251136.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000251138.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000251141.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000251143.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000251144.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000251148.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000251151.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000251151.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000251151.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000251161.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000251179.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000251179.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000251221.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000251257.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000251281.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000251301.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000251307.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000251307.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000251331.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000251350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000251359.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000251408.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000251450.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000251562.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000251577.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000251602.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000251611.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000251613.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000251615.3 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000251661.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000251666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000253174.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000253187.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000253197.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000253197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000253284.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000253315.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000253327.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000253385.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000253395.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000253399.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000253414.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000253433.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000253476.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000253530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000253552.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000253559.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000253559.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000253567.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000253576.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000253582.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000253641.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000253695.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000253704.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000253720.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000253730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000253733.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000253741.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000253741.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000253837.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000253878.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000253892.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000253893.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000253930.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000253961.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000253974.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000254028.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000254044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000254153.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000254153.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000254207.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000254224.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000254231.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000254258.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000254258.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000254263.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000254263.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000254275.2 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000254295.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000254295.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000254343.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000254353.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000254397.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000254427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000254432.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000254459.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000254468.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000254473.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000254473.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000254484.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000254485.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000254486.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000254495.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000254526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000254554.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000254606.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000254607.2 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000254632.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000254699.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000254718.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000254812.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000254837.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000254842.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000254860.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000254862.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000254864.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000254869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000254872.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000254910.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000255084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000255089.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000255090.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000255094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000255136.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000255142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000255142.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000255145.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000255153.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000255164.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000255227.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000255237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000255241.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000255276.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000255289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000255435.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000255449.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000255455.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000255487.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000255503.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000255507.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000255568.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000255580.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000255966.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000255970.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000255992.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000256006.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000256008.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000256050.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000256050.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000256116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000256150.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000256312.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000256381.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000256443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000256564.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000256576.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000256588.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000256596.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000256603.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000256789.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000256884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000256943.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000256967.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000257027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000257052.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000257052.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000257256.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000257261.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000257337.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000257438.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000257449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000257449.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000257551.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000257556.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000257585.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000257613.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000257642.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000257671.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000257681.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000257696.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000257696.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000257698.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000257761.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000257809.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000257829.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000257830.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000257880.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000257880.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000257886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000257925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000257947.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000257999.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000258017.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000258044.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000258077.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000258082.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000258122.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000258171.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000258172.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000258172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000258268.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000258344.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000258345.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000258378.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000258412.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000258414.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000258457.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000258457.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000258525.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000258526.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000258553.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000258558.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000258593.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000258612.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000258658.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000258689.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000258730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000258811.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000258821.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000258843.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000258851.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000258857.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000258858.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000258891.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000258922.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000258940.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000258949.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000258952.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000258976.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000258982.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000258998.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000258999.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000259005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259038.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000259055.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259088.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000259115.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000259125.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000259153.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000259163.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000259172.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000259172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259182.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000259188.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000259209.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000259209.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000259215.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259240.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000259248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259251.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259254.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259283.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259310.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000259319.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000259327.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000259327.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000259362.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000259366.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000259376.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000259438.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000259442.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000259448.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000259448.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000259450.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000259456.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000259462.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000259462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259488.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000259488.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259584.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000259584.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000259594.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259595.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000259606.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000259606.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000259610.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259618.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000259623.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000259623.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000259628.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000259628.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000259654.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000259654.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259668.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259673.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000259678.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259678.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000259692.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259701.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000259714.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000259715.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000259723.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000259723.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259727.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000259727.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000259736.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000259756.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259762.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000259762.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259771.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000259772.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000259772.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259783.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000259783.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259802.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000259807.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000259818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259820.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000259840.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259867.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000259867.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000259886.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000259888.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000259891.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000259891.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000259891.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000259891.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000259894.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000259915.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000259915.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000259921.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000259933.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000259935.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000259935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000259942.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000259943.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000259969.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000260005.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260011.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000260018.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260037.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000260046.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260051.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260052.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000260060.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260063.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000260065.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000260065.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000260081.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000260083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260086.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260100.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000260101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260118.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000260136.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000260141.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000260156.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000260160.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000260193.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260213.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000260236.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260253.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000260281.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000260285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260285.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000260288.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000260288.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000260316.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000260329.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260329.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260331.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260351.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000260352.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000260361.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260368.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000260369.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260388.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260394.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260417.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260466.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000260468.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000260470.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000260475.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260487.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000260488.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260507.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260515.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260519.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260526.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000260534.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000260541.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260565.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000260579.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000260583.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000260589.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000260597.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000260608.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260613.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000260613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260613.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000260618.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000260619.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000260625.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260626.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000260626.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000260630.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000260655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260655.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000260661.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260672.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000260698.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000260708.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260743.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000260743.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260750.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000260751.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000260757.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000260757.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260766.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260777.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260805.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000260805.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000260805.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000260805.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260807.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000260814.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260830.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000260833.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260834.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000260841.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000260874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260877.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260877.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000260905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260912.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000260920.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000260927.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000260929.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000260931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000260942.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000260947.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000260949.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000260949.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000260978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000260986.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000260992.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000261000.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000261000.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261003.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000261024.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000261026.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000261033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261043.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261098.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000261117.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000261124.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000261126.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000261159.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000261173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261186.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000261188.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000261188.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000261191.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261200.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261204.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000261211.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000261216.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000261220.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000261242.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000261252.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000261269.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000261280.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000261286.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000261291.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000261295.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261295.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000261318.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261324.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000261329.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000261329.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000261334.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000261338.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000261338.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000261360.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000261372.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000261390.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000261392.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000261416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261420.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261428.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000261431.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000261431.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261433.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000261437.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000261438.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261442.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000261442.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000261447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261451.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000261462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261474.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000261474.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261490.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000261523.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000261560.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000261574.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000261589.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000261610.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000261662.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000261662.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261671.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000261693.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000261697.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000261703.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261737.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261744.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000261744.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000261758.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000261760.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000261765.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000261766.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000261770.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000261775.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000261804.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000261824.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000261827.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000261840.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000261886.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000262001.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000262061.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000262074.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000262098.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000262099.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000262119.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000262136.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000262136.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000262136.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000262228.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000262228.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000262265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000262312.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000262339.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000262362.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000262370.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000262454.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000262482.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000262482.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000262580.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000262678.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000262693.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000262721.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000262772.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000262823.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000262833.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000262837.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000262879.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000262881.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000262905.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000262951.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000262979.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000263011.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000263098.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000263105.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000263120.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000263164.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000263214.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000263280.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000263280.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000263293.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000263327.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000263350.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000263370.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000263470.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000263477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000263586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000263718.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000263727.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000263727.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000263766.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000263786.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000263924.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000264043.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000264207.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000264207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000264207.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000264207.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000264222.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000264260.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000264270.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000264546.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000264569.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000264672.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000264673.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000264769.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000264769.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000264808.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000264920.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000264940.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000265055.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000265094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000265185.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000265242.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000265342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000265474.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000265485.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000265490.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000265542.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000265688.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000265739.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000265743.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000265778.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000265800.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000266079.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000266079.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000266088.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000266111.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000266126.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000266261.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000266261.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000266283.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000266304.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000266446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000266473.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000266538.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000266654.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000266654.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000266677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000266709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000266824.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000266900.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000266904.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000266904.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000266921.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000266922.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000266926.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000266934.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000266936.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000266947.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000266955.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000266969.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000266993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000266999.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000266999.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267024.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000267067.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267080.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267089.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000267093.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267104.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000267130.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000267130.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000267131.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000267150.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267151.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000267151.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267152.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000267159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000267172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000267174.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000267174.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267197.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000267198.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000267201.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000267212.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000267212.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000267231.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000267244.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267248.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267262.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000267265.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000267273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000267288.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000267289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000267289.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267296.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000267298.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000267299.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000267316.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000267321.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267322.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000267334.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267342.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000267366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000267374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000267405.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000267405.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000267419.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267454.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000267476.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000267480.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000267480.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000267480.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267481.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000267481.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000267510.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267547.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000267549.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267549.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000267565.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000267565.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000267567.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000267567.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000267568.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267581.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000267606.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000267638.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000267649.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000267655.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267658.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000267666.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267667.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000267672.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000267677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000267715.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000267715.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267730.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267734.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000267737.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000267745.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000267750.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000267764.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000267776.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000267778.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000267798.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000267868.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000268015.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000268049.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000268061.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000268093.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000268095.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000268095.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000268201.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000268201.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000268204.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000268204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000268230.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000268230.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000268257.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000268262.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000268262.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000268364.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000268375.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000268401.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000268536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000268605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000268605.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000268605.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000268650.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000268650.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000268683.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000268756.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000268836.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000268895.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000268938.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000268945.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000269044.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000269066.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000269091.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000269107.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000269161.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000269235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000269290.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000269290.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000269352.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000269397.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000269487.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000269487.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000269535.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000269560.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000269614.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000269646.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000269737.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000269814.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000269843.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000269867.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000269887.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000269892.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000269896.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000269903.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000269921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000269925.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000269927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000269946.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000269947.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000269949.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000269950.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000269966.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000269973.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000269974.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000269980.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000269983.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000269983.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000269983.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000270006.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000270020.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000270022.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000270022.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000270028.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000270028.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000270035.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000270039.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000270049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000270055.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000270069.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000270081.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000270081.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000270083.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000270091.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000270115.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000270117.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000270117.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000270120.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000270127.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000270154.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000270159.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000270210.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000270210.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000270223.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000270332.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000270332.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000270346.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000270419.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000270426.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000270426.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000270487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000270557.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000270557.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000270589.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000270605.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000270659.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000270681.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000270704.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000270726.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000270742.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000270761.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000270761.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000270828.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000270883.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000270951.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000270964.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000270964.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000271009.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000271032.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000271032.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000271133.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000271151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000271200.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000271200.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000271265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000271314.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000271324.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000271344.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000271359.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000271367.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000271384.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000271387.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000271427.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000271430.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000271522.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000271551.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000271631.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000271659.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000271755.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000271757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000271761.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000271762.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000271789.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000271789.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000271815.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000271815.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000271826.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000271833.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000271835.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000271840.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000271849.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000271855.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000271856.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000271871.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000271874.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000271912.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000271914.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000271938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000271952.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000271963.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000271964.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000271964.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000271981.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000271983.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000271983.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000271991.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000271993.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000271993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000271996.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000271998.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272029.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000272033.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000272048.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272065.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000272070.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000272071.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000272076.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000272077.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272086.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000272087.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000272087.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000272102.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000272109.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000272128.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000272128.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000272142.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272144.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000272146.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000272148.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000272161.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000272168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272183.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000272183.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000272216.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272219.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000272226.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272250.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000272265.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000272265.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000272273.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000272288.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272312.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000272312.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272324.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272328.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272328.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272346.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000272354.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000272361.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000272365.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272368.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000272368.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000272370.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000272372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272374.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000272375.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000272417.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000272426.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000272431.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272444.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272446.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000272449.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272452.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272462.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272463.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000272516.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272518.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272520.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000272524.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272525.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000272558.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000272564.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000272620.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272645.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272646.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272657.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272659.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000272660.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000272663.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272682.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272688.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272688.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000272691.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000272699.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000272699.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272702.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272709.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000272716.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272721.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272735.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272744.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000272744.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000272746.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000272755.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000272758.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272760.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272769.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000272791.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000272791.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000272795.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000272798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272808.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000272815.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000272825.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000272829.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272829.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272832.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000272849.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000272849.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272864.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000272864.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272871.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000272888.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000272892.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000272902.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000272905.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000272905.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000272908.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000272931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272931.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000272933.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cytarabine |
ENSG00000272933.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272940.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000272940.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000272960.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000272966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000272970.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000272983.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000272983.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000272984.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000273001.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000273004.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000273007.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000273008.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000273009.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000273015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000273018.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000273026.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000273058.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000273061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000273066.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000273076.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000273081.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000273084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000273091.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000273096.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000273097.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000273104.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000273108.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000273125.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000273132.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000273142.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000273143.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000273145.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000273145.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000273148.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cytarabine |
ENSG00000273153.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000273156.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000273162.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000273165.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000273175.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000273181.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000273183.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000273183.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Cytarabine |
ENSG00000273185.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000273186.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000273216.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000273218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000273237.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000273245.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cytarabine |
ENSG00000273248.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000273248.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000273253.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000273257.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000273265.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000273265.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000273265.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000273270.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000273270.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000273289.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Cytarabine |
ENSG00000273289.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000273289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000273290.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000273295.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000273297.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cytarabine |
ENSG00000273301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000273305.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000273306.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000273307.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000273309.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000273311.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000273335.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000273342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000273344.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000273355.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cytarabine |
ENSG00000273355.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000273373.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
ENSG00000273406.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cytarabine |
ENSG00000273406.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000273416.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cytarabine |
ENSG00000273424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000273456.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cytarabine |
ENSG00000273464.1 |
Predicted lncRNA |
Sarcoma |
|
| Cytarabine |
ENSG00000273473.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cytarabine |
ENSG00000273473.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cytarabine |
ENSG00000273476.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cytarabine |
ENSG00000273483.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cytarabine |
let-7a |
Curated miRNA |
acute myeloid leukemia |
|
| Cytarabine |
miR-10a |
Curated miRNA |
acute myeloid leukemia |
|
| Cytarabine |
miR-10b |
Curated miRNA |
acute myeloid leukemia |
|
| Cytarabine |
miR-126 |
Curated miRNA |
acute myeloid leukemia |
|
| Cytarabine |
miR-146a |
Curated miRNA |
leukemic monocytic cells |
|
| Cytarabine |
miR-181a |
Curated miRNA |
leukaemia |
|
| Cytarabine |
miR-181b |
Curated miRNA |
acute myeloid leukemia |
|
| Cytarabine |
miR-21 |
Curated miRNA |
leukemia |
|
| Cytarabine |
miR-32 |
Curated miRNA |
myeloid leukemia |
|